Auteur L. MITCHESON
|
Documents disponibles écrits par cet auteur (9)
Ajouter le résultat à votre sélection Affiner la recherche
J. McCAMBRIDGE ; A. WINSTOCK ; N. HUNT ; L. MITCHESON | 2007
Dans European Addiction Research (Vol.13, n°1, 2007) Article : PériodiqueAIMS: To describe and assess trends in the use of hallucinogens and other adjunct drugs over a 5-year period. DESIGN: Repeated-measures cross-sectional survey. SETTING AND PARTICIPANTS: Annual magazine-based survey targeting people who use drugs[...]J. McCAMBRIDGE ; L. MITCHESON ; A. WINSTOCK ; N. HUNT | 2005
Dans Addiction (Vol.100, n°8, August 2005) Article : PériodiqueAims To describe and evaluate trends in the use of stimulant drugs over a 5-year period using an under-studied data collection method. Design Repeated-measures cross-sectional survey. Setting and participants Annual magazine-based survey targeti[...]ENGLISH : Reductions in the prevalence and extent of current cannabis use among British nightclubbers have been reported in an annual survey conducted over the five years 19992003 inclusive. The generalizability and potential significance of t[...]A. WINSTOCK ; L. MITCHESON ; J. RAMSEY ; S. DAVIES ; M. PUCHNAREWICZ ; J. MARSDEN | 2011
Dans Addiction (Vol.106, n°11, November 2011) Article : PériodiqueAIMS To assess the patterns of use, subjective effect profile and dependence liability of mephedrone, supported by corroborative urine toxicology. DESIGN Cross-sectional structured telephone interview. Setting UK-based drug users associated wi[...]L. WIESSING ; M. FERRI ; V. BELACKOVA ; P. CARRIERI ; S. R. FRIEDMAN ; C. FOLCH ; K. DOLAN ; B. GALVIN ; P. VICKERMAN ; J. V. LAZARUS ; V. MRAVCIK ; M. KRETZSCHMAR ; V. SYPSA ; A. SARASA-RENEDO ; A. UUSKULA ; D. PARASKEVIS ; L. MENDAO ; D. ROSSI ; N. VAN GELDER ; L. MITCHESON ; L. PAOLI ; C. DIAZ GOMEZ ; M. MILHET ; N. DASCALU ; J. KNIGHT ; G. HAY ; E. KALAMARA ; R. SIMON ; C. M. COMISKEY ; C. ROSSI ; P. GRIFFITHS ; EUBEST working group | 2017
Dans Harm Reduction Journal (Vol.14, n°19, 2017) Article : PériodiqueBackground and aims: Despite advances in our knowledge of effective services for people who use drugs over the last decades globally, coverage remains poor in most countries, while quality is often unknown. This paper aims to discuss the histori[...]A. R. WINSTOCK ; L. MITCHESON | 2012
Dans British Medical Journal (Vol.344, n°7844, 18 February 2012) Article : PériodiqueIn recent years, hundreds of new drugs have appeared on the recreational drugs market in Europe. Some of these substances, such as ketamine and γ-hydroxybutyrate (GHB), have legitimate medical purposes. These compounds have been joined by many n[...]E. DAY, Auteur ; L. MITCHESON, Auteur ; P. M. FLYNN, Auteur du commentaire ; C. J. STRIKE ; A. GUTA ; J. SELIN ; D. RAISTRICK ; E. DAY ; L. MITCHESON, Auteur du commentaire | 2017
Dans Addiction (Vol.112, n°8, August 2017) Article : PériodiqueBackground and Aims: Clinical guidelines from around the world recommend the delivery of psychosocial interventions as part of routine care in opiate substitution treatment (OST) programmes. However, although individual studies demonstrate benef[...]'Harm reduction' is a term that is used to refer both to a set of general principles used to underpin policies concerning the way that societies respond to drug problems and, simultaneously, to some specific types of intervention, such as needle[...]T. WEAVER ; N. METREBIAN ; J. HELLIER ; S. PILLING ; V. CHARLES ; N. LITTLE ; D. POOVENDRAN ; L. MITCHESON ; F. RYAN ; O. BOWDEN-JONES ; J. DUNN ; GLASPER A. ; E. FINCH ; J. STRANG | 2014
Dans Lancet (The) (Vol.384, n°9938, July 12, 2014) Article : PériodiqueBACKGROUND. Poor adherence to treatment diminishes its individual and public health benefit. Financial incentives, provided on the condition of treatment attendance, could address this problem. Injecting drug users are a high-risk group for hepa[...]